Tag: university
-
Carb-X Funding Nanoscale Sponge to Treat Sepsis
A company developing tiny particles made of cellular material to soak-up toxins in the body received a $4 million award to advance its sepsis treatment.
-
Software Designed to Model, Visualize Brain Circuits
An academic-industry team designed a web-based software tool to ease the computer modeling, simulation, and visualization of the brain’s nerve cell circuits.
-
Covid-19 Vaccine Challenge Trial Underway
Researchers in the U.K. are beginning a human challenge trial that intentionally exposes volunteers to SARS-CoV-2 viruses to test candidate vaccines.
-
Lilly Gains Neuro Disease Biotech in $1.36B Deal
Drug maker Eli Lilly and Co. is acquiring Disarm Therapeutics, a biotechnology company developing treatments for neurodegenerative disorders.
-
Cancer Center, Biotech Partner on Off-the-Shelf T-Cells
MD Anderson Cancer Center and Allogene Therapeutics Inc. agreed to jointly study the company’s cancer treatments derived from donated T-cells.
-
Blood Test Shown to Predict Covid-19 Symptom Severity
A blood test that measures the ratio of two key immune system proteins is shown in tests with patients to predict the severity of Covid-19 symptoms.
-
Gene Therapy Delivery Tech Licensed in $1.8B Deal
A biotechnology company creating synthetic viruses with artificial intelligence to deliver gene therapies is licensing its technology to drug maker Roche.
-
Individual Cells Explored with Virtual Reality
A new software package uses virtual reality to allow biologists and medical researchers to visualize and explore inside individual cells in three dimensions.
-
Start-Up Gains Access to Vaccine Nasal Spray Technology
A company developing techniques to deliver vaccines like Covid-19 with a nasal spray received an opportunity to license the process from University of Houston.
-
New Funds Advance Hand-Wrist Neural Rehab Device
Developers of a system to help people with spinal cord injuries regain use of their hands and wrists, are configuring the device for home use.